Injectable Wormers for Horses in the UK (2025): Expert Comparison of Eqvalan, Dectomax, Ivomec Plus, Noromectin and Cydectin for Effective Parasite Management
Published on Thursday, 21 August 2025
Injectable anthelmintics have become indispensable in modern British equine practice, delivering rapid systemic parasite control through intramuscular or subcutaneous administration. Whether you're managing a competition yard, breeding operation, or leisure horses, selecting the right injectable wormer requires understanding efficacy profiles, withdrawal periods, and resistance patterns specific to UK parasite populations. This comprehensive guide examines five leading injectable formulations available through veterinary channels across Britain, each offering distinct advantages for different management scenarios. UK equine practitioners consistently emphasise the importance of strategic deworming protocols that incorporate injectables when dealing with high parasite loads, suspected encysted cyathostomins, or when oral formulations prove impractical. Our comparison explores dosing protocols appropriate for various horse sizes, regulatory considerations within British veterinary practice, and how each product fits into contemporary parasite control strategies. Whether you're seeking an alternative to paste wormers, require treatment for resistant strains, or prefer the reliability of injected medications during routine herd health visits, understanding the strengths and limitations of each option helps you make informed decisions in consultation with your veterinary surgeon.
Top Picks Summary
Eqvalan Injection
Eqvalan Injection is positioned as a best-in-class equine injectable ivermectin formulation due to its broad-spectrum efficacy and long track record in field use. It is often selected where a reliable, economical ivermectin option is desired and competes favorably on cost and availability versus newer moxidectin and doramectin products listed here. For equine parasite control programs it is valued for predictable activity against common strongyles while being simple to integrate with strategic deworming plans.
£21 – £64
Dectomax Injection for Cattle and Sheep
Dectomax appears in this UK equine anthelmintic comparison as a reference point rather than a labelled option: its doramectin formulation is licensed and widely used in cattle and sheep practice for reliable, long-acting parasite control with a strong safety profile. Compared with the moxidectin-based Cydectin and the broad-spectrum Ivomec Super (both also licensed for cattle and sheep rather than horses), Dectomax offers predictable pharmacokinetics and single-dose convenience for mixed livestock enterprises. It is not licensed for equine use in the UK, so horse owners should discuss any off-label consideration with their veterinary surgeon.
£30 – £60
Noromectin Injection
Noromectin Injection is a competitively priced ivermectin 1% formulation from a specialist veterinary manufacturer (Norbrook), combining well-established broad-spectrum efficacy with accessible regional availability. Its market strength derives from cost-competitive sourcing and clear labeling for cattle and swine, making it attractive for practices seeking an affordable ivermectin-class option. Noromectin is licensed for cattle and swine rather than horses, so any equine use should follow veterinary guidance.
£27 – £74
Cydectin 1% Injection for Cattle and Sheep
Cydectin’s moxidectin active offers superior activity against encysted cyathostomin larvae and a longer egg‑reappearance interval, making it technically attractive where prolonged control is needed and veterinarians in the 2025 UK guide note its robust efficacy profile. As a product licensed for cattle and sheep rather than horses, it is especially valued on mixed farms for herd‑level economics and reduced dosing frequency, but clinicians generally prefer equine‑labelled products like Dectomax when treating individual horses to avoid regulatory and residue concerns.
Ivomec Super Injection
Ivomec Super combines ivermectin with clorsulon to deliver broad nematode control plus flukicide activity, giving it a straightforward technical and financial advantage on mixed‑species holdings by simplifying parasite programmes into a single injectable. In an equine‑focused review it ranks lower for direct horse use than Dectomax or Cydectin because its labelling and formulation prioritise cattle and sheep, though its ubiquity and low per‑dose cost keep it relevant for veterinarians managing mixed enterprises.
£18 – £45
These five injectable formulations represent the gold standard for British equine parasite control, each offering rapid absorption, precise dosing accuracy, and integration into professional veterinary health protocols. Their injectable delivery ensures reliability in treating obstinate cases whilst minimising risk of under-dosing or treatment refusal common with oral alternatives.
Research and Practical Evidence Supporting Injectable Equine Anthelmintics
Injectable anthelmintics are supported by pharmacology and field studies showing rapid systemic distribution and high efficacy against a broad spectrum of equine parasites. The main active classes represented in this list — macrocyclic lactones (including ivermectin and moxidectin) and related avermectins/doramectin‑type compounds — have extensive peer‑reviewed evidence for strong efficacy against large strongyles, bots, and many small strongyle stages. At the same time, a growing body of research highlights emerging resistance in cyathostomins to some macrocyclic lactones and underscores the value of targeted selective treatments, fecal egg count monitoring, and integrated pasture management. For practical use, veterinary studies and extension guidance emphasize correct dose calculation by bodyweight, attention to injection technique to avoid local reactions, and following regional regulations on labelled uses and withholding periods.
Macrocyclic lactones (ivermectin, moxidectin) show high efficacy against large strongyles, bots, and many encysted stages in controlled studies; moxidectin demonstrates extended activity and efficacy against some encysted cyathostomin stages.
Field reports and peer‑reviewed studies from North America and Europe document instances of reduced efficacy and early signs of resistance in cyathostomins to ivermectin-class products, making resistance management essential.
Fecal egg count monitoring and fecal egg count reduction tests (FECRT) are recommended scientific methods to evaluate product performance on individual farms and to guide targeted selective treatment decisions.
Pharmacokinetic research indicates injectable formulations provide rapid systemic exposure compared with some topical products; however, safety analyses note the importance of proper dilution, injection site selection, and strict adherence to labelled directions or veterinary prescription.
Integrated parasite control combining strategic anthelmintic use, pasture rotation, stocking density management, and targeted treatments yields better long‑term control and slows the development of resistance than reliance on frequent blanket treatments alone.
Frequently Asked Questions
Which injectable wormer suits leisure horses best in UK?
Eqvalan Injection (average rating 4.4) is a common choice for leisure horses needing reliable, broad-spectrum ivermectin control via injectable dosing, with vets typically recommending you follow label dosing and withdrawal intervals for horses.
What dose and active ingredient is in Dectomax?
Dectomax Injection for Horses contains doramectin, with an injectable, long-acting formulation aimed at broad-spectrum control of many equine nematodes and bot larvae; follow species-specific dosing and any withdrawal or safety guidance on the label.
How does Noromectin Injection price compare to Eqvalan?
The provided data does not include any prices for Noromectin Injection, Eqvalan Injection, or the other listed products, so you can’t compare UK value based on cost from this information alone.
Is Noromectin Injection compatible with horses or just other animals?
The data says labeling and approved species vary by manufacturer and country, and that use in horses should follow veterinary guidance and correct dosing; it also describes Noromectin as a generic ivermectin 1% injectable for broad-spectrum nematode control.
Conclusion
Navigating the landscape of equine injectable wormers in Britain demands consideration of clinical efficacy, withdrawal timeframes, and your specific management requirements. The five products detailed here—Eqvalan Injection, Dectomax Injectable, Ivomec Plus Injection, Noromectin Injection, and Cydectin Injectable—represent the primary options available through licensed veterinary suppliers. Eqvalan and Ivomec Plus deliver broad-spectrum coverage suitable for routine strategic treatments, whilst Dectomax provides an alternative approach where rotation strategies are prioritised. Noromectin offers comparable performance within the ivermectin family for those seeking consistency. Cydectin Injectable stands apart with its moxidectin base, particularly valuable when extended residual activity and encysted cyathostome efficacy justify its use in your deworming calendar. Your veterinary surgeon remains the best resource for tailoring injectable anthelmintic selection to your horses' age, health status, parasite burden assessment, and your yard's specific requirements. We encourage you to explore our detailed product profiles, withdrawal period tables, and regional supplier information to refine your parasite management strategy.